• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rallybio Corporation - Common Stock (NQ:RLYB)

14.30 +0.09 (+0.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 53,619
Open 14.16
Bid (Size) 13.70 (100)
Ask (Size) 14.99 (100)
Prev. Close 14.21
Today's Range 13.91 - 14.50
52wk Range 2.160 - 15.31
Shares Outstanding 37,747,433
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks are moving in today's session ↗
May 04, 2026
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
May 04, 2026
Via Chartmill

Performance

YTD
+152.7%
+152.7%
1 Month
+72.7%
+72.7%
3 Month
+196.7%
+196.7%
6 Month
+179.2%
+179.2%
1 Year
+458.4%
+458.4%

More News

Read More
Traders are paying attention to the gapping stocks in Monday's session. ↗
May 04, 2026
Via Chartmill
Discover the top movers in Monday's pre-market session. ↗
May 04, 2026
Via Chartmill
RALLYBIO CORP (NASDAQ:RLYB) Passes Minervini Trend and High Growth Momentum Filters ↗
March 30, 2026
Via Chartmill
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN)
April 09, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether RLYB, TALK, UNF are Obtaining Fair Deals for their Shareholders
March 19, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rallybio Corporation (Nasdaq – RLYB), SunOpta Inc. (Nasdaq – STKL), Talkspace, Inc. (Nasdaq - TALK), Kennedy-Wilson Holdings, Inc. (Nasdaq - KW)
March 18, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether TALK, JTAI, RLYB are Obtaining Fair Deals for their Shareholders
March 17, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB
March 04, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
Monday's session: top gainers and losers ↗
March 02, 2026
Via Chartmill
News headline image
RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Deal for its Shareholders
March 02, 2026
From Halper Sadeh LLC
Via Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
March 02, 2026
Via Chartmill
News headline image
Rallybio Corporation and Candid Therapeutics Announce Merger Agreement
March 02, 2026
From Candid Therapeutics, Inc.
Via Business Wire
News headline image
Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
February 17, 2026
From Rallybio Corporation
Via Business Wire
News headline image
Rallybio Announces Reverse Stock Split of Common Stock
February 03, 2026
From Rallybio Corporation
Via Business Wire
News headline image
RALLYBIO CORP (NASDAQ:RLYB) Reports Q3 2025 Earnings Beat Fueled by Asset Sale and Advances Clinical Pipeline ↗
November 06, 2025
Via Chartmill
Topics Earnings
News headline image
Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 06, 2025
From Rallybio Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
October 23, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
October 16, 2025
Via Benzinga
News headline image
Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
September 25, 2025
From Rallybio Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
September 23, 2025
Via Benzinga
News headline image
Rallybio Receives $12.5 Million Equity Milestone Payment from Recursion for Advancement of REV102 Program
September 03, 2025
From Rallybio Corporation
Via Business Wire
News headline image
Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
August 12, 2025
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 07, 2025
From Rallybio Corporation
Via Business Wire

Frequently Asked Questions

Is Rallybio Corporation - Common Stock publicly traded?
Yes, Rallybio Corporation - Common Stock is publicly traded.
What exchange does Rallybio Corporation - Common Stock trade on?
Rallybio Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Rallybio Corporation - Common Stock?
The ticker symbol for Rallybio Corporation - Common Stock is RLYB on the Nasdaq Stock Market
What is the current price of Rallybio Corporation - Common Stock?
The current price of Rallybio Corporation - Common Stock is 14.30
When was Rallybio Corporation - Common Stock last traded?
The last trade of Rallybio Corporation - Common Stock was at 05/15/26 04:00 PM ET
What is the market capitalization of Rallybio Corporation - Common Stock?
The market capitalization of Rallybio Corporation - Common Stock is 539.79M
How many shares of Rallybio Corporation - Common Stock are outstanding?
Rallybio Corporation - Common Stock has 540M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap